Qiuqiong Tang

Insilicos (United States)

Papers

1

Total Citations

11

H-Index

1

About

Dr. Qiuqiong Tang is a pioneering researcher at the intersection of artificial intelligence, robotics, and aging biology. Her work focuses on developing automated, AI-driven platforms to accelerate the discovery of therapeutics that target fundamental aging processes. In her landmark 2024 study, "AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent," Dr. Tang demonstrated a powerful new approach by using a fully automated laboratory to screen for compounds that modulate cellular senescence—a core hallmark of aging. This work identified TNIK inhibition as a promising senomorphic strategy, capable of mitigating age-related cellular dysfunction without inducing toxicity. Already garnering 11 citations in its first year, this study showcases her ability to merge cutting-edge computational methods with high-throughput biological experimentation. By establishing a framework for simultaneously targeting aging and disease, Dr. Tang is helping to redefine how longevity therapeutics are prioritized and developed. Her contributions are paving the way for a new era of precision geroscience, where AI and robotics work in concert to uncover dual-purpose interventions for healthier aging.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Insilicos (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago